Ensysce Biosciences Inc.(ENSC)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

ENSC Ensysce Biosciences Inc.

交易中 07-15 10:09:13 EDT

2.30

+0.10

+4.55%

最高2.30	最低2.21	成交量2.18万
今开2.30	昨收2.20	日振幅4.09%
总市值545.26万	流通市值411.08万	总股本237.07万
成交额4.94万	换手率1.22%	流通股本178.73万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"ENSC","market":"US","secType":"STK","nameCN":"Ensysce Biosciences Inc.","latestPrice":2.3,"timestamp":1752588529428,"preClose":2.2,"halted":0,"volume":21789,"delay":0,"floatShares":1787300,"shares":2370698,"eps":-11.448165,"marketStatus":"交易中","change":0.1,"latestTime":"07-15 10:09:13 EDT","open":2.3,"high":2.3,"low":2.21,"amount":49350.6752517,"amplitude":0.040909,"askPrice":2.3,"askSize":100,"bidPrice":2.25,"bidSize":42,"shortable":3,"etf":0,"ttmEps":-11.448165,"tradingStatus":2,"nextMarketStatus":{"tag":"盘后交易","tradingStatus":3,"beginTime":1752609600000},"marketStatusCode":2,"adr":0,"exchange":"NASDAQ","adjPreClose":2.2,"preHourTrading":{"tag":"盘前","latestPrice":2.3,"preClose":2.2,"latestTime":"09:25 EDT","volume":2994,"amount":6844.749567,"timestamp":1752585932753},"postHourTrading":{"tag":"盘后","latestPrice":2.27,"preClose":2.2,"latestTime":"18:57 EDT","volume":170,"amount":385.04,"timestamp":1752533824264},"volumeRatio":1.427574,"impliedVol":3.1521,"impliedVolPercentile":0},"requestUrl":"/m/hq/s/ENSC","defaultTab":"news","newsList":[{"id":"2551187579","title":"Ensysce Biosciences, Inc.盘中异动 早盘快速拉升5.05%报2.27美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2551187579","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2551187579?lang=zh_cn&edition=full","pubTime":"2025-07-14 23:09","pubTimestamp":1752505745,"startTime":"0","endTime":"0","summary":"北京时间2025年07月14日23时09分，Ensysce Biosciences, Inc.股票出现异动，股价快速拉升5.05%。Ensysce Biosciences, Inc.股票所在的生物技术行业中，整体涨幅为1.26%。其相关个股中，Sonnet Biotherapeutics Holdings, Inc.、Dare Bioscience, Inc.、Promis Neurosciences Inc.涨幅较大，Windtree Therapeutics, Inc.、Sonnet Biotherapeutics Holdings, Inc.、Dare Bioscience, Inc.较为活跃，换手率分别为1958.02%、989.62%、614.06%，振幅较大的相关个股有Promis Neurosciences Inc.、Dare Bioscience, Inc.、Sonnet Biotherapeutics Holdings, Inc.，振幅分别为210.04%、178.93%、148.16%。Ensysce Biosciences, Inc.公司简介：Ensysce Biosciences Inc是一家临床阶段的生物技术公司，采用其专有技术平台开发更安全的处方药。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250714230906a6a917ba&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250714230906a6a917ba&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ENSC","BK4139"],"gpt_icon":0},{"id":"2550627849","title":"Ensysce Biosciences, Inc.盘中异动 股价大跌5.36%","url":"https://stock-news.laohu8.com/highlight/detail?id=2550627849","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2550627849?lang=zh_cn&edition=full","pubTime":"2025-07-11 00:20","pubTimestamp":1752164402,"startTime":"0","endTime":"0","summary":"北京时间2025年07月11日00时20分，Ensysce Biosciences, Inc.股票出现异动，股价大幅跳水5.36%。Ensysce Biosciences, Inc.股票所在的生物技术行业中，整体涨幅为0.56%。其相关个股中，Q32 Bio Inc.、Pelthos Therapeutics Inc.、Lixte Biotechnology Holdings  Inc C/Wts 30/11/2025 涨幅较大，Cognition Therapeutics, Inc.、Q32 Bio Inc.、Calidi Biotherapeutics, Inc.较为活跃，换手率分别为368.37%、316.71%、252.37%，振幅较大的相关个股有Q32 Bio Inc.、Lixte Biotechnology Holdings  Inc C/Wts 30/11/2025 、Cognition Therapeutics, Inc.，振幅分别为90.07%、74.89%、73.27%。Ensysce Biosciences, Inc.公司简介：Ensysce Biosciences Inc是一家临床阶段的生物技术公司，采用其专有技术平台开发更安全的处方药。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025071100200297a12b10&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025071100200297a12b10&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ENSC","BK4139"],"gpt_icon":0},{"id":"2550216125","title":"Ensysce Biosciences, Inc.盘中异动 临近午盘股价大跌5.19%","url":"https://stock-news.laohu8.com/highlight/detail?id=2550216125","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2550216125?lang=zh_cn&edition=full","pubTime":"2025-07-08 23:50","pubTimestamp":1751989852,"startTime":"0","endTime":"0","summary":"北京时间2025年07月08日23时50分，Ensysce Biosciences, Inc.股票出现异动，股价快速跳水5.19%。Ensysce Biosciences, Inc.股票所在的生物技术行业中，整体涨幅为1.28%。其相关个股中，Zyversa Therapeutics, Inc.、Rallybio Corporation、Seastar Medical Holding Corporation涨幅较大，Zyversa Therapeutics, Inc.、Moleculin Biotech, Inc.、Rallybio Corporation较为活跃，换手率分别为2271.49%、570.03%、322.75%，振幅较大的相关个股有Zyversa Therapeutics, Inc.、Lixte Biotechnology Holdings  Inc C/Wts 30/11/2025 、Cero Therapeutics Holdings Inc C/Wts 13/02/2029 ，振幅分别为87.67%、73.34%、70.96%。Ensysce Biosciences, Inc.公司简介：Ensysce Biosciences Inc是一家临床阶段的生物技术公司，采用其专有技术平台开发更安全的处方药。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250708235052979e842c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250708235052979e842c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ENSC","BK4139"],"gpt_icon":0},{"id":"2545233207","title":"Ensysce Biosciences, Inc.盘中异动 股价大涨5.63%","url":"https://stock-news.laohu8.com/highlight/detail?id=2545233207","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2545233207?lang=zh_cn&edition=full","pubTime":"2025-06-24 21:44","pubTimestamp":1750772680,"startTime":"0","endTime":"0","summary":"北京时间2025年06月24日21时44分，Ensysce Biosciences, Inc.股票出现异动，股价急速拉升5.63%。Ensysce Biosciences, Inc.股票所在的生物技术行业中，整体涨幅为0.29%。其相关个股中，内克塔治疗、Vor Biopharma Inc.、Ibio, Inc.涨幅较大，Adial Pharmaceuticals, Inc、Ibio, Inc.、Plus Therapeutics, Inc.较为活跃，换手率分别为503.84%、308.78%、239.86%，振幅较大的相关个股有Vor Biopharma Inc.、内克塔治疗、Nls Pharmaceutics Ltd C/Wts 02/02/2026，振幅分别为48.55%、38.68%、34.76%。Ensysce Biosciences, Inc.公司简介：Ensysce Biosciences Inc是一家临床阶段的生物技术公司，采用其专有技术平台开发更安全的处方药。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250624214440978ced00&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250624214440978ced00&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ENSC"],"gpt_icon":0},{"id":"2543481544","title":"Ensysce Biosciences, Inc.盘中异动 下午盘快速拉升5.08%","url":"https://stock-news.laohu8.com/highlight/detail?id=2543481544","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2543481544?lang=zh_cn&edition=full","pubTime":"2025-06-13 03:04","pubTimestamp":1749755085,"startTime":"0","endTime":"0","summary":"北京时间2025年06月13日03时04分，Ensysce Biosciences, Inc.股票出现异动，股价急速拉升5.08%。Ensysce Biosciences, Inc.股票所在的生物技术行业中，整体涨幅为0.77%。其相关个股中，Klotho Neurosciences Inc C/Wts 21/06/2029 、Liminatus Pharma Inc C/Wts 30/04/2030 、Liminatus Pharma, Inc.涨幅较大，Nucana Plc、Polyrizon Ltd.、Klotho Neurosciences, Inc.较为活跃，换手率分别为3611.73%、879.43%、377.78%，振幅较大的相关个股有Klotho Neurosciences Inc C/Wts 21/06/2029 、Liminatus Pharma Inc C/Wts 30/04/2030 、Liminatus Pharma, Inc.，振幅分别为256.24%、171.50%、87.67%。Ensysce Biosciences, Inc.公司简介：Ensysce Biosciences Inc是一家临床阶段的生物技术公司，采用其专有技术平台开发更安全的处方药。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250613030445a4a5bd94&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250613030445a4a5bd94&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ENSC"],"gpt_icon":0},{"id":"2537166654","title":"Ensysce Biosciences, Inc.5月23日成交额为6.94万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2537166654","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2537166654?lang=zh_cn&edition=full","pubTime":"2025-05-24 09:41","pubTimestamp":1748050911,"startTime":"0","endTime":"0","summary":"美东时间2025年5月23日，Ensysce Biosciences, Inc.成交额为6.94万美元，成交额较昨日减少46.67%，当日成交量为3.19万股。Ensysce Biosciences, Inc.于2025年5月23日涨1.38%，报2.2美元，该股过去5个交易日跌5.98%，年初至今跌72.97%，过去60日跌58.1%。|近5个交易日成交情况||||#|日期|成交额（美元）|成交额较昨日变化|成交量（股）|#|2025-05-23|6.94万|-46.67%|3.19万|#|2025-05-22|13.02万|-64.58%|6.06万|#|2025-05-21|36.76万|109.66%|16.43万|#|2025-05-20|17.53万|-67.77%|7.23万|#|2025-05-19|54.40万|18.55%|21.68万|Ensysce Biosciences Inc是一家临床阶段的生物技术公司，采用其专有技术平台开发更安全的处方药。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250524094201a6eae5c7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250524094201a6eae5c7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ENSC","BK4139"],"gpt_icon":0},{"id":"2536636667","title":"Ensysce Biosciences, Inc.2025财年第一财季实现净利润-1.95百万美元，同比增加37.50%","url":"https://stock-news.laohu8.com/highlight/detail?id=2536636667","media":"市场透视","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2536636667?lang=zh_cn&edition=full","pubTime":"2025-05-20 00:00","pubTimestamp":1747670439,"startTime":"0","endTime":"0","summary":"5月20日，Ensysce Biosciences, Inc.公布财报，公告显示公司2025财年第一财季净利润为-1.95百万美元，同比增加37.50%；其中营业收入为1.32百万美元，同比增加331.76%，每股基本收益为-1.39美元。从资产负债表来看，Ensysce Biosciences, Inc.总负债1.89百万美元，其中短期债务240068.00美元，资产负债比为2.44，流动比率为2.50。机构评级：截至2025年5月20日，当前有1家机构对Ensysce Biosciences, Inc.目标价做出预测，其中目标均价为18.45美元，其中最低目标价为18.45美元，最高目标价为18.45美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250520000104a6e4f006&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250520000104a6e4f006&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ENSC"],"gpt_icon":0},{"id":"2535056931","title":"Ensysce Biosciences, Inc.5月13日成交额为145.47万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2535056931","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2535056931?lang=zh_cn&edition=full","pubTime":"2025-05-14 09:36","pubTimestamp":1747186581,"startTime":"0","endTime":"0","summary":"美东时间2025年5月13日，Ensysce Biosciences, Inc.成交额为145.47万美元，成交额较昨日增加394.23%，当日成交量为69.64万股。Ensysce Biosciences, Inc.于2025年5月13日跌5.48%，报2.07美元，该股过去5个交易日跌4.61%，年初至今跌74.57%，过去60日跌64.31%。|近5个交易日成交情况||||#|日期|成交额（美元）|成交额较昨日变化|成交量（股）|#|2025-05-13|145.47万|394.23%|69.64万|#|2025-05-12|29.43万|218.47%|13.63万|#|2025-05-09|9.24万|-35.36%|4.25万|#|2025-05-08|14.30万|-40.56%|6.92万|#|2025-05-07|24.05万|-35.74%|11.31万|Ensysce Biosciences Inc 是一家临床阶段的生物技术公司，利用其专有技术平台开发更安全的处方药。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250514093629a6de3c5f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250514093629a6de3c5f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ENSC"],"gpt_icon":0},{"id":"2534113011","title":"Ensysce Biosciences, Inc.5月8日成交额为14.30万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2534113011","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2534113011?lang=zh_cn&edition=full","pubTime":"2025-05-09 09:32","pubTimestamp":1746754347,"startTime":"0","endTime":"0","summary":"美东时间2025年5月8日，Ensysce Biosciences, Inc.成交额为14.30万美元，成交额较昨日减少40.56%，当日成交量为6.92万股。Ensysce Biosciences, Inc.于2025年5月8日涨1.46%，报2.08美元，该股过去5个交易日跌29.97%，年初至今跌74.45%，过去60日跌62.45%。|近5个交易日成交情况||||#|日期|成交额（美元）|成交额较昨日变化|成交量（股）|#|2025-05-08|14.30万|-40.56%|6.92万|#|2025-05-07|24.05万|-35.74%|11.31万|#|2025-05-06|37.43万|100.49%|16.82万|#|2025-05-05|18.67万|-64.09%|7.56万|#|2025-05-02|52.00万|52.06%|19.76万|Ensysce Biosciences Inc 是一家临床阶段的生物技术公司，利用其专有技术平台开发更安全的处方药。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250509093245a6d86475&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250509093245a6d86475&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ENSC","BK4139"],"gpt_icon":0},{"id":"2533691639","title":"Ensysce Biosciences, Inc.5月7日成交额为24.05万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2533691639","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2533691639?lang=zh_cn&edition=full","pubTime":"2025-05-08 09:32","pubTimestamp":1746667943,"startTime":"0","endTime":"0","summary":"美东时间2025年5月7日，Ensysce Biosciences, Inc.成交额为24.05万美元，成交额较昨日减少35.74%，当日成交量为11.31万股。Ensysce Biosciences, Inc.于2025年5月7日跌5.53%，报2.05美元，该股过去5个交易日跌32.12%，年初至今跌74.82%，过去60日跌64.66%。|近5个交易日成交情况||||#|日期|成交额（美元）|成交额较昨日变化|成交量（股）|#|2025-05-07|24.05万|-35.74%|11.31万|#|2025-05-06|37.43万|100.49%|16.82万|#|2025-05-05|18.67万|-64.09%|7.56万|#|2025-05-02|52.00万|52.06%|19.76万|#|2025-05-01|34.20万|-24.18%|11.23万|Ensysce Biosciences Inc 是一家临床阶段的生物技术公司，利用其专有技术平台开发更安全的处方药。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250508093230a4760338&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250508093230a4760338&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ENSC"],"gpt_icon":0},{"id":"2533539032","title":"Ensysce Biosciences, Inc.盘中异动 早盘大幅跳水5.43%","url":"https://stock-news.laohu8.com/highlight/detail?id=2533539032","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2533539032?lang=zh_cn&edition=full","pubTime":"2025-05-05 23:07","pubTimestamp":1746457657,"startTime":"0","endTime":"0","summary":"北京时间2025年05月05日23时07分，Ensysce Biosciences, Inc.股票出现波动，股价快速下跌5.43%。Ensysce Biosciences, Inc.股票所在的生物技术行业中，整体涨幅为0.84%。其相关个股中，Nls Pharmaceutics Ltd C/Wts 02/02/2026、Nucana Plc、Apollomics Inc C/Wts 01/04/2028 涨幅较大，Nucana Plc、Scisparc Ltd.、Polyrizon Ltd.较为活跃，换手率分别为907.34%、615.70%、77.76%，振幅较大的相关个股有Nls Pharmaceutics Ltd C/Wts 02/02/2026、Coeptis Therapeutics Holdings Inc C/Wts 28/10/2027 、Polyrizon Ltd.，振幅分别为156.25%、113.27%、57.43%。Ensysce Biosciences, Inc.公司简介：Ensysce Biosciences Inc 是一家临床阶段的生物技术公司，利用其专有技术平台开发更安全的处方药。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250505230737a472e985&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250505230737a472e985&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ENSC","BK4139"],"gpt_icon":0},{"id":"2532580437","title":"Ensysce Biosciences, Inc.5月2日成交额为52.00万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2532580437","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2532580437?lang=zh_cn&edition=full","pubTime":"2025-05-03 09:30","pubTimestamp":1746235859,"startTime":"0","endTime":"0","summary":"美东时间2025年5月2日，Ensysce Biosciences, Inc.成交额为52.00万美元，成交额较昨日增加52.06%，当日成交量为19.76万股。Ensysce Biosciences, Inc.于2025年5月2日跌13.47%，报2.57美元，该股过去5个交易日跌21.88%，年初至今跌68.43%，过去60日跌58.48%。|近5个交易日成交情况||||#|日期|成交额（美元）|成交额较昨日变化|成交量（股）|#|2025-05-02|52.00万|52.06%|19.76万|#|2025-05-01|34.20万|-24.18%|11.23万|#|2025-04-30|45.10万|-60.66%|14.99万|#|2025-04-29|114.63万|4.03%|37.35万|#|2025-04-28|110.19万|-63.70%|37.02万|Ensysce Biosciences Inc 是一家临床阶段的生物技术公司，利用其专有技术平台开发更安全的处方药。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250503093102a6d19809&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250503093102a6d19809&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ENSC","BK4139"],"gpt_icon":0},{"id":"2532009618","title":"Ensysce Biosciences, Inc.盘中异动 早盘急速上涨5.30%","url":"https://stock-news.laohu8.com/highlight/detail?id=2532009618","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2532009618?lang=zh_cn&edition=full","pubTime":"2025-05-01 21:53","pubTimestamp":1746107583,"startTime":"0","endTime":"0","summary":"北京时间2025年05月01日21时53分，Ensysce Biosciences, Inc.股票出现异动，股价急速拉升5.30%。Ensysce Biosciences, Inc.股票所在的生物技术行业中，整体跌幅为1.40%。其相关个股中，Transcode Therapeutics, Inc.、Seastar Medical Holding Corp C/Wts 28/10/2027 、Psyence Biomedical Ltd C/Wts 25/01/2029涨幅较大，Transcode Therapeutics, Inc.、Processa Pharmaceuticals, Inc.、Onconetix, Inc.较为活跃，换手率分别为96.28%、35.37%、16.79%，振幅较大的相关个股有Transcode Therapeutics, Inc.、Psyence Biomedical Ltd C/Wts 25/01/2029、Psyence Biomedical Ltd.，振幅分别为36.89%、24.75%、18.78%。Ensysce Biosciences, Inc.公司简介：Ensysce Biosciences Inc 是一家临床阶段的生物技术公司，利用其专有技术平台开发更安全的处方药。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025050121530394e9f955&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025050121530394e9f955&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ENSC","BK4139"],"gpt_icon":0},{"id":"2532017637","title":"Ensysce Biosciences, Inc.4月30日成交额为45.10万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2532017637","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2532017637?lang=zh_cn&edition=full","pubTime":"2025-05-01 09:31","pubTimestamp":1746063078,"startTime":"0","endTime":"0","summary":"美东时间2025年4月30日，Ensysce Biosciences, Inc.成交额为45.10万美元，成交额较昨日减少60.66%，当日成交量为14.99万股。Ensysce Biosciences, Inc.于2025年4月30日跌0.98%，报3.02美元，该股过去5个交易日跌17.71%，年初至今跌62.9%，过去60日跌54.24%。|近5个交易日成交情况||||#|日期|成交额（美元）|成交额较昨日变化|成交量（股）|#|2025-04-30|45.10万|-60.66%|14.99万|#|2025-04-29|114.63万|4.03%|37.35万|#|2025-04-28|110.19万|-63.70%|37.02万|#|2025-04-25|303.52万|-43.39%|91.28万|#|2025-04-24|536.19万|-98.52%|169.84万|Ensysce Biosciences Inc 是一家临床阶段的生物技术公司，利用其专有技术平台开发更安全的处方药。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250501093120a6cf869b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250501093120a6cf869b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ENSC"],"gpt_icon":0},{"id":"2531742205","title":"Ensysce Biosciences, Inc.4月29日成交额为114.63万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2531742205","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2531742205?lang=zh_cn&edition=full","pubTime":"2025-04-30 09:30","pubTimestamp":1745976639,"startTime":"0","endTime":"0","summary":"美东时间2025年4月29日，Ensysce Biosciences, Inc.成交额为114.63万美元，成交额较昨日增加4.03%，当日成交量为37.35万股。Ensysce Biosciences, Inc.于2025年4月29日涨4.1%，报3.05美元，该股过去5个交易日涨63.1%，年初至今跌62.53%，过去60日跌55.6%。|近5个交易日成交情况||||#|日期|成交额（美元）|成交额较昨日变化|成交量（股）|#|2025-04-29|114.63万|4.03%|37.35万|#|2025-04-28|110.19万|-63.70%|37.02万|#|2025-04-25|303.52万|-43.39%|91.28万|#|2025-04-24|536.19万|-98.52%|169.84万|#|2025-04-23|3.62亿|250819.29%|9205.43万|Ensysce Biosciences Inc 是一家临床阶段的生物技术公司，利用其专有技术平台开发更安全的处方药。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250430093311a6ce1713&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250430093311a6ce1713&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ENSC","BK4139"],"gpt_icon":0},{"id":"2531753471","title":"Ensysce Biosciences, Inc.盘中异动 早盘股价大涨5.12%","url":"https://stock-news.laohu8.com/highlight/detail?id=2531753471","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2531753471?lang=zh_cn&edition=full","pubTime":"2025-04-29 21:54","pubTimestamp":1745934880,"startTime":"0","endTime":"0","summary":"北京时间2025年04月29日21时54分，Ensysce Biosciences, Inc.股票出现异动，股价急速拉升5.12%。Ensysce Biosciences, Inc.股票所在的生物技术行业中，整体跌幅为1.50%。其相关个股中，Cyclacel Pharmaceuticals, Inc.、Conduit Pharmaceuticals Inc C/Wts 22/09/2028、Lixte Biotechnology Holdings  Inc C/Wts 30/11/2025 涨幅较大，Zyversa Therapeutics, Inc.、Onconetix, Inc.、Galmed Pharmaceuticals Ltd.较为活跃，换手率分别为138.68%、57.20%、22.70%，振幅较大的相关个股有Spruce Biosciences, Inc.、Cyclacel Pharmaceuticals, Inc.、Briacell Therapeutics Corp C/Wts 26/02/2026，振幅分别为31.68%、26.68%、22.81%。Ensysce Biosciences, Inc.公司简介：Ensysce Biosciences Inc 是一家临床阶段的生物技术公司，利用其专有技术平台开发更安全的处方药。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250429215440a6cd6f89&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250429215440a6cd6f89&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ENSC","BK4139"],"gpt_icon":0},{"id":"2531216517","title":"Ensysce Biosciences, Inc.4月28日成交额为110.19万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2531216517","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2531216517?lang=zh_cn&edition=full","pubTime":"2025-04-29 09:30","pubTimestamp":1745890217,"startTime":"0","endTime":"0","summary":"美东时间2025年4月28日，Ensysce Biosciences, Inc.成交额为110.19万美元，成交额较昨日减少63.70%，当日成交量为37.02万股。Ensysce Biosciences, Inc.于2025年4月28日跌10.94%，报2.93美元，该股过去5个交易日涨76.51%，年初至今跌64.0%，过去60日跌56.33%。|近5个交易日成交情况||||#|日期|成交额（美元）|成交额较昨日变化|成交量（股）|#|2025-04-28|110.19万|-63.70%|37.02万|#|2025-04-25|303.52万|-43.39%|91.28万|#|2025-04-24|536.19万|-98.52%|169.84万|#|2025-04-23|3.62亿|250819.29%|9205.43万|#|2025-04-22|14.44万|4.38%|8.18万|Ensysce Biosciences Inc 是一家临床阶段的生物技术公司，利用其专有技术平台开发更安全的处方药。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250429093143a46b403b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250429093143a46b403b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ENSC"],"gpt_icon":0},{"id":"2530428147","title":"Ensysce Biosciences, Inc.盘中异动 早盘快速跳水5.46%","url":"https://stock-news.laohu8.com/highlight/detail?id=2530428147","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2530428147?lang=zh_cn&edition=full","pubTime":"2025-04-28 21:31","pubTimestamp":1745847098,"startTime":"0","endTime":"0","summary":"北京时间2025年04月28日21时31分，Ensysce Biosciences, Inc.股票出现异动，股价快速跳水5.46%。Ensysce Biosciences, Inc.股票所在的生物技术行业中，整体涨幅为0.35%。其相关个股中，Galmed Pharmaceuticals Ltd.、Cg Oncology, Inc.、Cingulate Inc C/Wts 10/12/2026 涨幅较大，Galmed Pharmaceuticals Ltd.、Portage Biotech Inc.、Tharimmune, Inc.较为活跃，换手率分别为1159.61%、310.57%、61.80%，振幅较大的相关个股有Portage Biotech Inc.、Galmed Pharmaceuticals Ltd.、Exozymes Inc.，振幅分别为16.55%、10.82%、10.07%。Ensysce Biosciences, Inc.公司简介：Ensysce Biosciences Inc 是一家临床阶段的生物技术公司，利用其专有技术平台开发更安全的处方药。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025042821313894e5f170&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025042821313894e5f170&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ENSC","BK4139"],"gpt_icon":0},{"id":"2530115165","title":"Ensysce Biosciences, Inc.4月25日成交额为303.52万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2530115165","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2530115165?lang=zh_cn&edition=full","pubTime":"2025-04-26 09:29","pubTimestamp":1745630989,"startTime":"0","endTime":"0","summary":"美东时间2025年4月25日，Ensysce Biosciences, Inc.成交额为303.52万美元，成交额较昨日减少43.39%，当日成交量为91.28万股。Ensysce Biosciences, Inc.于2025年4月25日跌0.6%，报3.29美元，该股过去5个交易日涨86.93%，年初至今跌59.58%，过去60日跌52.53%。|近5个交易日成交情况||||#|日期|成交额（美元）|成交额较昨日变化|成交量（股）|#|2025-04-25|303.52万|-43.39%|91.28万|#|2025-04-24|536.19万|-98.52%|169.84万|#|2025-04-23|3.62亿|250819.29%|9205.43万|#|2025-04-22|14.44万|4.38%|8.18万|#|2025-04-21|13.83万|-40.66%|8.26万|Ensysce Biosciences Inc 是一家临床阶段的生物技术公司，利用其专有技术平台开发更安全的处方药。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250426092956a46786e2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250426092956a46786e2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ENSC"],"gpt_icon":0},{"id":"2530513008","title":"Ensysce Biosciences, Inc.盘中异动 股价大跌6.34%","url":"https://stock-news.laohu8.com/highlight/detail?id=2530513008","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2530513008?lang=zh_cn&edition=full","pubTime":"2025-04-25 21:32","pubTimestamp":1745587925,"startTime":"0","endTime":"0","summary":"北京时间2025年04月25日21时32分，Ensysce Biosciences, Inc.股票出现异动，股价急速下跌6.34%。Ensysce Biosciences, Inc.股票所在的生物技术行业中，整体跌幅为0.47%。其相关个股中，Azitra Inc、Lixte Biotechnology Holdings, Inc.、Geovax Labs, Inc.涨幅较大，Azitra Inc、Briacell Therapeutics Corp.、Acrivon Therapeutics, Inc.较为活跃，换手率分别为187.74%、41.72%、40.53%，振幅较大的相关个股有Azitra Inc、Polyrizon Ltd.、Acrivon Therapeutics, Inc.，振幅分别为13.07%、8.57%、8.22%。Ensysce Biosciences, Inc.公司简介：Ensysce Biosciences Inc 是一家临床阶段的生物技术公司，利用其专有技术平台开发更安全的处方药。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250425213206a6c81d35&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250425213206a6c81d35&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ENSC"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.ensysce.com","stockEarnings":[{"period":"1week","weight":-0.0476},{"period":"1month","weight":0.0628},{"period":"3month","weight":-0.0179},{"period":"6month","weight":-0.6927},{"period":"1year","weight":-0.6815},{"period":"ytd","weight":-0.7297}],"compareEarnings":[{"period":"1week","weight":0.0067},{"period":"1month","weight":0.0466},{"period":"3month","weight":0.1622},{"period":"6month","weight":0.054},{"period":"1year","weight":0.1158},{"period":"ytd","weight":0.0661}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Ensysce Biosciences, Inc.于2003年4月在特拉华州注册成立。该公司是一家临床阶段的生物技术公司，利用其专有技术平台开发更安全的处方药。利用其胰蛋白酶激活滥用保护和多药滥用抗性平台，该公司正在开发一类新的强大、防篡改的阿片类药物，可防止药物滥用和过量服用。预计Ensysce的产品将提供更安全的选择来治疗严重的疼痛，并有助于预防阿片类药物滥用造成的死亡，从而降低人力和经济成本。","yearOnYearQuotes":[{"month":1,"riseRate":0.428571,"avgChangeRate":-0.044599},{"month":2,"riseRate":0.142857,"avgChangeRate":-0.166672},{"month":3,"riseRate":0.375,"avgChangeRate":-0.106138},{"month":4,"riseRate":0.25,"avgChangeRate":-0.051395},{"month":5,"riseRate":0.5,"avgChangeRate":-0.125258},{"month":6,"riseRate":0.75,"avgChangeRate":0.040392},{"month":7,"riseRate":0.375,"avgChangeRate":-0.139922},{"month":8,"riseRate":0.285714,"avgChangeRate":-0.117865},{"month":9,"riseRate":0.428571,"avgChangeRate":-0.163949},{"month":10,"riseRate":0.428571,"avgChangeRate":0.079948},{"month":11,"riseRate":0.571429,"avgChangeRate":-0.03576},{"month":12,"riseRate":0.714286,"avgChangeRate":0.198533}],"exchange":"NASDAQ","name":"Ensysce Biosciences Inc.","nameEN":"Ensysce Biosciences Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.34.3","shortVersion":"4.34.3","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Ensysce Biosciences Inc.(ENSC)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Ensysce Biosciences Inc.(ENSC)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Ensysce Biosciences Inc.,ENSC,Ensysce Biosciences Inc.股票,Ensysce Biosciences Inc.股票老虎,Ensysce Biosciences Inc.股票老虎国际,Ensysce Biosciences Inc.行情,Ensysce Biosciences Inc.股票行情,Ensysce Biosciences Inc.股价,Ensysce Biosciences Inc.股市,Ensysce Biosciences Inc.股票价格,Ensysce Biosciences Inc.股票交易,Ensysce Biosciences Inc.股票购买,Ensysce Biosciences Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Ensysce Biosciences Inc.(ENSC)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Ensysce Biosciences Inc.(ENSC)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}